[HTML][HTML] Advances in understanding N-glycosylation structure, function, and regulation in health and disease

S Esmail, MF Manolson - European journal of cell biology, 2021 - Elsevier
N-linked glycosylation is a post-translational modification crucial for membrane protein
folding, stability and other cellular functions. Alteration of membrane protein N-glycans is …

[HTML][HTML] Emerging role of ubiquitination in the regulation of PD-1/PD-L1 in cancer immunotherapy

X Hu, J Wang, M Chu, Y Liu, Z Wang, X Zhu - Molecular Therapy, 2021 - cell.com
A growing amount of evidence suggests that ubiquitination and deubiquitination of
programmed death 1 (PD-1)/programmed death-ligand 1 (PD-L1) play crucial roles in the …

D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1

R Zhang, Y Yang, W Dong, M Lin… - Proceedings of the …, 2022 - National Acad Sciences
Breast cancer is the most frequent malignancy in women worldwide, and triple-negative
breast cancer (TNBC) patients have the worst prognosis and highest risk of recurrence. The …

Therapeutic blocking of VEGF binding to neuropilin-2 diminishes PD-L1 expression to activate antitumor immunity in prostate cancer

M Wang, CA Wisniewski, C Xiong, P Chhoy… - Science Translational …, 2023 - science.org
Prostate cancers are largely unresponsive to immune checkpoint inhibitors (ICIs), and there
is strong evidence that programmed death-ligand 1 (PD-L1) expression itself must be …

Molecularly imprinted polymers (MIPs): emerging biomaterials for cancer theragnostic applications

MS Kang, E Cho, HE Choi, C Amri, JH Lee… - Biomaterials …, 2023 - spj.science.org
Cancer is a disease caused by abnormal cell growth that spreads through other parts of the
body and threatens life by destroying healthy tissues. Therefore, numerous techniques have …

Recent advancements in the B7/CD28 immune checkpoint families: new biology and clinical therapeutic strategies

MC Pulanco, AT Madsen, A Tanwar… - Cellular & Molecular …, 2023 - nature.com
The B7/CD28 families of immune checkpoints play vital roles in negatively or positively
regulating immune cells in homeostasis and various diseases. Recent basic and clinical …

In Situ Sprayed Nanovaccine Suppressing Exosomal PD-L1 by Golgi Apparatus Disorganization for Postsurgical Melanoma Immunotherapy

H Ye, K Wang, J Zhao, Q Lu, M Wang, B Sun, Y Shen… - ACS …, 2023 - ACS Publications
The anti-PD-L1 immunotherapy has shown promise in treating cancer. However, certain
patients with metastatic cancer have low response and high relapse rates. A main reason is …

Ovarian cancer in the era of immune checkpoint inhibitors: state of the art and future perspectives

BA Maiorano, MFP Maiorano, D Lorusso, E Maiello - Cancers, 2021 - mdpi.com
Simple Summary Ovarian cancer (OC) represents the fifth leading cause of cancer-related
deaths among women. In the advanced disease setting, OC recurrence after chemotherapy …

Challenges Coexist with Opportunities: Spatial Heterogeneity Expression of PD‐L1 in Cancer Therapy

Y Wang, Y Zhou, L Yang, L Lei, B He, J Cao… - Advanced …, 2024 - Wiley Online Library
Cancer immunotherapy using anti‐programmed death‐ligand 1 (PD‐L1) antibodies has
been used in various clinical applications and achieved certain results. However, such …

Stabilization of EREG via STT3B-mediated N-glycosylation is critical for PDL1 upregulation and immune evasion in head and neck squamous cell carcinoma

S Xu, H Wang, Y Zhu, Y Han, L Liu, X Zhang… - International Journal of …, 2024 - nature.com
Dysregulated Epiregulin (EREG) can activate epidermal growth factor receptor (EGFR) and
promote tumor progression in head and neck squamous cell carcinoma (HNSCC). However …